UnitedHealth Group reported strong third-quarter results, with revenue and earnings growth across key segments and raised its 2021 earnings outlook. Management expressed confidence in continued growth, highlighted significant membership increases, and anticipated lower COVID-related impacts next year. The positive financial performance and optimistic guidance are likely to have a positive short-term impact on the stock price.

[1]